BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 7, 2026
Home » Authors » Jim Stommen

Jim Stommen

Articles

ARTICLES

The MDD Interview: Director of Medical Devices Center sees changes for industry

June 21, 2012
By Jim Stommen
Arthur Erdman, PhD, is the Richard C. Jordan Professor and a Morse Alumni Distinguished Teaching Professor of Mechanical Engineering at the University of Minnesota, specializing in mechanical design, bioengineering and product design. In July 2007 he was selected as the director of the Medical Devices Center at the university. Erdman has published more than 325 technical papers, three books, and holds more than 30 patents.
Read More

Consumers take their own tweet time using social media for health questions

June 12, 2012
By Jim Stommen
OK, social media mavens – this one’s for you. This coming from someone who, whenever I see or hear a reference to a Tweet, automatically rack up the chorus to Bobby Day’s golden oldie “Rockin’ Robin” (yes, and the Jackson 5, but Bobby Day’s was the original, in 1958): “Rockin' robin (tweet tweet tweet) Rockin' robin (tweet tweet tweet) Oh rockin' robin well you really gonna rock tonight” But I digress . . . This is about the use of social media to discuss health issues. According to a recent PricewaterhouseCoopers (PwC) report, more than 40% of all U.S. adults...
Read More

The MDD Interview: GE healthymagination Fund invests on 'mega-trends'

June 7, 2012
By Jim Stommen
Rafael Torres co-leads the GE healthymagination Fund. He previously worked in several roles at GE Healthcare (Chalfont, UK), including in mergers and acquisitions such as GE's $10 billion acquisition of Amersham, and serves on the board of several GE portfolio companies.
Read More

The MDD Interview: Hoping that benefits, needs can carry the day for new products

May 31, 2012
By Jim Stommen
Robert Ward is chairman of Emergence Venture Partners, president of ExThera Medical (both Berkeley, California), and founder and former president of the Polymer Technology Group (PTG), now DSM Biomedical.
Read More

MedTech Investing Conference: 'Elsewhere' seen as alternative locales for financings, trials

May 21, 2012
By Jim Stommen

The MDD Interview: Dealing with 'nasty disease states' creates opportunities for EKOS

May 17, 2012
By Jim Stommen
Robert Hubert is president/CEO of EKOS (Bothell, Washington), bringing to EKOS more than 20 years of marketing, sales, and general management experience in a broad range of medical device companies, from start-up to Fortune 10.
Read More

MedTech Investing Conference: For reimbursement, it's all about the effect on outcomes

May 17, 2012
By Jim Stommen

MedTech Investing Conference: Leahey: Stakes for med-tech sector have never been higher

May 16, 2012
By Jim Stommen

MedTech Investing Conference: Changing partnership models reflect new paths to business

May 15, 2012
By Jim Stommen
MINNEAPOLIS Things go in cycles, they say. That certainly appears to be true insofar as pharmaceutical company ownership of medical device companies is concerned.
Read More

MedTech Investing Conference: Mixed numbers show VCs still conflicted on med-tech

May 14, 2012
By Jim Stommen
MINNEAPOLIS The numbers were, as they say, staggering. When asked by conference co-chairman Kevin Wasserstein how many in the audience of nearly 400 attendees at the 11th annual MedTech Investing Conference here last week felt business conditions for the med-tech sector were better now than a year earlier, the number of hands raised could have made up the starting teams in an NBA game at the Target Center across the street.
Read More
View All Articles by Jim Stommen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing